Eckard Weber
2009
In 2009, Eckard Weber earned a total compensation of $46.7K as Interim President, Chief Executive Officer and Chairman of the Board of Directors at Orexigen Therapeutics, a 66% decrease compared to previous year.
Compensation breakdown
| Option Awards | $21,726 |
|---|---|
| Other | $25,000 |
| Total | $46,726 |
Weber received $25K in other compensation, accounting for 54% of the total pay in 2009.
Weber also received $21.7K in option awards.
Rankings
In 2009, Eckard Weber's compensation ranked 9,812th out of 9,885 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,812 out of 9,885 | 1st |
Division Manufacturing | 3,659 out of 3,690 | 1st |
Major group Chemicals And Allied Products | 859 out of 866 | 1st |
Industry group Drugs | 631 out of 638 | 1st |
Industry Pharmaceutical Preparations | 440 out of 446 | 1st |
Source: SEC filing on April 28, 2010.
Weber's colleagues
We found seven more compensation records of executives who worked with Eckard Weber at Orexigen Therapeutics in 2009.
2009
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2009
Dawn Viveash
Orexigen Therapeutics
Senior Vice President, Regulatory Affairs
2009
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2009
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2009
Heather Turner
Orexigen Therapeutics